MDG Forum: Software as a Medical Device (SaMD)
January 8, 2020
Hamilton Brook Smith Reynolds was proud to sponsor the Medical Development Group (MDG) Forum "Software as a Medical Device (SaMD)” at Regis College Fine Arts Center on January 8, 2020. Panelists discussed current trends in Software as a Medical Device (SaMD) including technology advances, regulatory challenges, and intellectual property strategies.
Adaptive software-based technologies, such as Artificial Intelligence (AI) and Machine Learning (ML), have the potential to adapt and enhance medical device performance in real-time by deriving insights from the vast data collected to continuously improve healthcare delivery for patients.
Among the high-value applications identified by the FDA for such technologies are earlier disease detection, more accurate diagnosis, and development of personalized diagnostics and therapeutics.
Principal, Mark Solomon from Hamilton Brook Smith Reynolds participated in the panel discussion.
The other members of the panel are:
- Scott Blood - Principal Quality and Regulatory Consultant at MEDIcept
- Navin Dewagan - President of Digital Health Solutions
- Dawn Bardot, Ph.D. - Director of Cloud-based Service Technologies Abiomed
- Stephen Pittman - MODERATOR - Principal, SD Pittman & Co. LLC
Alexander Adam, Ph.D., Principal at Hamilton Brook Smith Reynolds was the organizer and Co-Champion of this event.
The Medical Development Group Boston (MDG Boston) is a community of individuals professionally committed to the Medical Device and other Medical Technology Industry segments united by the belief that innovation and advances in technology lead to substantial improvements in health care.